SP0159 WHAT DO WE KNOW – WHAT SHALL WE DO – WHAT DO WE TELL. (June 2019)

• Record Type: Journal Article
• Authors: Radstake, Timothy R.
• Is Part Of: Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
• Page Start: 48
• Page End: 49
• Publication Date: 2019-06
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2019-eular.8568
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : There is an increasing need for patients to be involved in research as well as matters that can influence their own clinical journey. One aspect of science that links optimal clinical care is the increased use of biomarkers for so-called personalized medicine approaches. In my presentation I will showcase the State of the Art technologies of biomarker research and how the information that comes from this can be implemented for improving clinical care. I will discuss the revolution of molecular profiling and how the large amount of data coming from these approaches is used to molecularly classify patients into molecular fingerprints. How this technology leads to a disruptive change in medicine for the coming 5-10 years. I will close of with the role of biomarkers in the treatment of diseases, trial design and drug development for the coming 5 years. Disclosure of Interests: None declared